Bioworld Financial Watch articles from November 2004

Bioworld Financial Watch archives from November 2004

Cancer drugs likely losers in reformed medicare rules.
November 1, 2004... As ever, cancer drugs were much in the news last week, with Onyx Pharmaceuticals Inc.'s stock taking a 33 percent hit after the firm disclosed a likely delay in getting its renal cancer drug approved--and the drugs are going to make headlines...

10 biggest U.S. gainers for the week.
November 1, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Avax Technol 81.82 Deltagen 50.00 StemCells 37.41 CVTherapeutics 34.92 Dendreon 33.25 Osteotech 22.43 Antigenics 21.98 Orchid ...

10 biggest U.S. losers for the week.
November 1, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Imcor -44.44 Onyx Pharma -31.24 Hana Bio -18.92 eXegenics -17.31 Genaissance -16.81 Xcyte Therapies -15.93 Miravant -15.65...

Collaborations between biotechnology companies and universities/ nonprofit institutions: Aug. 5-Oct. 27, 2004.
November 1, 2004... Collaborations Between Biotechnology Companies And Universities/Nonprofit Institutions: Aug. 5 -- Oct. 27, 2004 Company * University/ Type Of (Country; Symbol) Nonprofit (@) Agreement AEterna...

BioWorld stock report for public biotechnology companies.
November 1, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 10/22 10/29 ...

Plexxikon scores as PPAR cloud fails to deter Wyeth.
November 8, 2004... Peter Hirth, CEO of Plexxikon Inc., doesn't mind crowing about the fact that, when the FDA issued an edict regarding PPAR drug development this summer, he was one of the few industry figures with enough gumption to talk about what it meant....

10 biggest U.S. gainers for the week.
November 8, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Interleukin 42.07 Genentech 5.43 CuraGen 23.73 United Thera 4.25 Hana Bio 23.33 Invitrogen ...

10 biggest U.S. losers for the week.
November 8, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Imcor -55.56 Digene -5 Corcept -22.97 Immucor -3.96 Ortec Int'l -21.74 Corcept ...

Correction.(Correction Notice)
November 8, 2004... An item in the Oct. 18, 2004, issue of BioWorld Financial Watch mischaracterized one of Salmedix Inc.'s products. SDX-102, l-alanosine, is being tested for brain tumors by a National Cancer Institute consortium in a Phase I/II trial. ...

Public financing of biotechnology: October 2004.
November 8, 2004... Public Financing Of Biotechnology: October 2004 I. COMMENCED TRADING IN SEPTEMBER Shares Company Date Date Shares/ Out (Symbol) (#) ...

Other financings of public biotechnology companies: October 2004.
November 8, 2004... Other Financings Of Public Biotechnology Companies: October 2004 TOTAL: $483.86M Number Of Shares, Units Amount Company Type Of ...

Venture capital and corporate investments in biotechnology companies: October 2004.
November 8, 2004... Venture Capital And Corporate Investments In Biotechnology Companies: October 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $396.57M Company Location Date Amt. (M) Acuity Philadelphia ...

BioWorld stock report for public biotechnology companies.
November 8, 2004... BioWorld Stock Report For Public Biotechnology Companies Close Close % Change Vol Company Symbol 10/29 11/5 WK YTD (000) Aastrom Biosci ASTM 1.2...

Medarex's landmark deal with BMS: 'what we set out to do'.
November 15, 2004... Industry leaders like to use phrases such as "going forward" and "as the company evolves," even though a troubling number of firms in biotechnology (and other industries) tend instead to stall, slide or die. An exception is Medarex Inc.,...

10 biggest U.S. gainers for the week.
November 15, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Immtech 38.78 Immucor 4.15 Imcor 35.00 Immtech 3.18 Lynx Therapeutics 32.00 ...

10 biggest U.S. losers for the week.
November 15, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Genta -28.08 NitroMed -5.95 NitroMed -23.17 Martek Bio -2.00 Novavax -18.08 Biogen...

Clinical trials update: October 2004.
November 15, 2004... Clinical Trials Update: October 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories (FDA-approved) ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: October 2004.
November 15, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel ...

FDA submissions, approvals and other actions: October 2004.
November 15, 2004... FDA Submissions, Approvals And Other Actions: October 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE La Jolla Riquent Abetimus sodium; B-cell Pharmaceutical ...

BioWorld stock report for public biotechnology companies.
November 15, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 11/5 11/12 Aastrom Biosci ASTM 1.13 1.01 Abgenix ...

Use of Velcade widening as various trials march on.(Integrilin Boosts Profitability Push)
November 22, 2004... When Millennium Pharmaceuticals Inc. nailed down its overseas marketing deal in July 2003 with Ortho Biotech Products LP for the multiple myeloma drug Velcade (approved two months earlier), investors sat up and took notice. The terms were...

10 biggest U.S. gainers for the week.
November 22, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Northwest BioThera 66.67 Biotime 31.93 Sonus Pharma 23.35 V.I. Technol 20.63 Access Pharma 20.00 MacroChem 19.61 GTx ...

10 biggest U.S. losers for the week.
November 22, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Durect -13.69 Transgenomic -13.16 Aphton -13.04 Xcyte Therapies -13.04 Interleukin -13.00 Peregrine Pharma -12.77 Miravant ...

Biotechnology company deals with other biotechnology companies: collaborations, agreements, equity participation, Sept. 17-Nov. 17, 2004.
November 22, 2004... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Sept. 17-Nov. 17, 2004 Company * Company * Type/Product Area (Country; (Country; Symbol)...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Sept. 17-Nov. 17, 2004.
November 22, 2004... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Sept. 17-Nov. 17, 2004 Company * Company Type/Product Area (Country; Symbol) Acacia Research ...

Manufacturing, marketing and distribution agreements between biotech companies: Sept. 17-Nov. 17, 2004.
November 22, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Sept. 17-Nov. 17, 2004 Company * Company * Product (Country; (Country; Symbol) Symbol) Acuity ...

Biotech-biotech collaborations: modified and terminated agreements, Sept. 17-Nov. 17, 2004.
November 22, 2004... Biotech-Biotech Collaborations: Modified And Terminated Agreements, Sept. 17-Nov. 17, 2004 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement Symbol)...

BioWorld stock report for public biotechnology companies.
November 22, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 11/12 11/19 WK...

Tysabri's Physician uptake remains question mark.(IV Route Could Complicate Picture)
November 29, 2004... Earlier this month when Biogen Idec Inc. at last unveiled one-year data from its Phase III trial known as AFFIRM, hopes of investors--not to mention multiple sclerosis patients--ran high for the would-be blockbuster Antegren (natalizumab). ...

10 biggest U.S. gainers for the week.
November 29, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) NeoPharm 49.81 Alnylam 33.67 Maxim Pharma 23.38 Aradigm 22.22 Bruker BioSciences 21.32 United Thera 18.31 Siga Technol...

10 biggest U.S. losers for the week.
November 29, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Alliance -29.63 Atherogenics -24.58 Connetics Corp. -23.25 OSI Pharma -15.04 Corcept -14.61 Ortec Int'l -13.89 V.I. Technol -11.84...

Biotech collaborations, other actions in agriculture and animals: Jan. 1-Nov. 23, 2004.
November 29, 2004... Biotech Collaborations, Other Actions in Agriculture and Animals: Jan. 1 - Nov. 23, 2004 Biotech Co. * Agbiotech Type/Product (Country; Partner/ Area Symbol) Institution ...

BioWorld Stock Report for public biotechnology companies.
November 29, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 11/19 11/24 ...